与IgG4相关的脏疾病:从脏组织病理学和免疫病原生成到新的药理干预措施
Eva Baier1, Augusto Vaglio2,3
1Department of Nephrology and Rheumatology, University Medical Center of Goettingen, Goettingen, Germany.
Expert review of clinical immunology
|October 13, 2025
概括
免疫球蛋白G4 (IgG4) 相关的病 (IgG4-RKD) 涉及复杂的免疫反应和纤维化. 本综述涵盖IgG4-RKD病理学和针对B细胞和T细胞的新疗法,用于未来的综合治疗策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 免疫球蛋白G4 (IgG4) 相关疾病 (IgG4-RD) 是一种罕见的纤维炎症疾病,导致器官损伤.
- 与IgG4相关的脏疾病 (IgG4-RKD) 是IgG4-RD的常见和严重表现,影响脏和泌尿器官.
- 免疫病原发生过程涉及B细胞,T细胞,抗体产生,细胞因子和纤维化.
研究的目的:
- 审查目前关于IgG4-RKD的知识,重点关注脏组织病理学和免疫病变发生.
- 为IgG4-RKD提供新型药理学干预措施的概述.
- 讨论未来可能的治疗策略.
主要方法:
- 关于IgG4-RD和IgG4-RKD当前科学进展的文献综述.
- 对涉及B细胞和T细胞子集的免疫病原发生的分析.
- 探索针对免疫细胞的药理干预措施.
主要成果:
- IgG4-RKD表现出独特的组织病理学和复杂的免疫病原发生.
- 目前正在探索针对B细胞和T细胞的各种药理干预措施.
- B细胞消耗剂和T细胞协同刺激调节剂是目前的治疗途径.
结论:
- 未来IgG4-RD的治疗可能需要综合策略,结合B细胞和T细胞向剂.
- 对IgG4-RKD免疫病原发生的持续研究对于开发有效疗法至关重要.
- 了解组织病理学是诊断和管理IgG4-RKD的关键.
关键词:
B细胞的枯竭导致B细胞的枯竭.针对B细胞的向疗法与IgG4相关的疾病与IgG4相关的脏疾病与IgG4相关的膜性脏病.在IgG4 - 管腔间歇性炎中.这是一种纤维炎症状况.纤维化 纤维化调节协同刺激的调节.更多相关视频
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
316
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
316
Acute Kidney Injury IV: Diagnostic Studies and Prevention
238
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
238
Acute Kidney Injury II: Pathophysiology
834
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
834
Chronic Kidney Disease I: Introduction
531
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
531
Acute Kidney Injury III: Clinical Manifestations
754
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
754
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
158
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
158


